Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,749 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,753 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01336192 | Maintenance Gemcitabine in the Chinese Advanced Lung Cancer(MAGICAL) | unknown | Phase 4 | 240 | Tongji UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00380718 | Chemotherapy for Patients With Non-Small Cell Lung Cancer | completed | Phase 4 | 33 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 16, 2010 | clinicaltrials |
| NCT01211002 |
| Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) |
| unknown |
| Phase 4 |
| 170 |
| Simcere Pharmaceutical Co., LtdOTHER |
| 1 |
| Sep 29, 2010 |
| clinicaltrials |
| NCT01000740 | A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa | completed | Phase 4 | 59 | AstraZenecaINDUSTRY | 1 | May 21, 2010 | clinicaltrials |
| NCT00813332 | Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 4 | 300 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 25, 2010 | clinicaltrials |
| NCT01028729 | A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)(NSCLC) | unknown | Phase 4 | 120 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00099541 | Non-small Cell Lung Cancer Registry | completed | Phase 4 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00115206 | Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | completed | Phase 4 | — | AmgenINDUSTRY | 0 | Apr 6, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Apr 15, 2011source: clinicaltrials